Eiger BioPharmaceuticals Reports on 2018 R&D Day

Author's Avatar
Dec 11, 2018
Article's Main Image

-- Late Stage Rare and Ultra-Rare Disease Pipeline Advancing

-- >$100M in Cash Available to Achieve Key Milestones

PR Newswire